Back
Avery Dennison 10K Form
Buy
53
AVY
Avery Dennison
Last Price:
$184.33
Seasonality Move:
3.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | AVY/Avery Dennison Quarterly |
2024-02-21 | 10K | AVY/Avery Dennison Annual |
2023-10-31 | 10Q | AVY/Avery Dennison Quarterly |
2023-08-01 | 10Q | AVY/Avery Dennison Quarterly |
2023-05-02 | 10Q | AVY/Avery Dennison Quarterly |
2023-02-22 | 10K | AVY/Avery Dennison Annual |
Receive AVY News And Ratings
See the #1 stock for the next 7 days that we like better than AVY
AVY Financial Statistics
Sales & Book Value
Annual Sales: | $8.8B |
---|---|
Cash Flow: | $272.8M |
Price / Cash Flow: | 21.3 |
Annual Sales: | $28.86 |
Price / Book: | 6.38 |
Profitability
EPS (TTM): | 8.72000 |
---|---|
Net Income (TTM): | $704.9M |
Gross Margin: | $2.5B |
Return on Equity: | 31.1% |
Return on Assets: | 8.47% |
Avery Dennison Earnings Forecast
Key Avery Dennison Financial Ratios
-
The Gross Profit Margin over the past 41 years for AVY is 28.90%.
-
The Selling, General & Administrative Expenses for AVY have been equal to 16.16% of Gross Profit Margin.
-
The Research & Development expenses have been 1.62% of Revenue.
-
The Interest Expense is 16.60% of Operating Income.
-
The Net Earning history of AVY is 8.05% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 27 years.
Avery Dennison Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | AVY |
CUSIP: | 053611 |
Website: | averydennison.com |
Debt
Debt-to-Equity Ratio: | 1.36 |
---|---|
Current Ratio: | 1.08 |
Quick Ratio: | 0.63 |
Price-to-Earnings
Trailing P/E Ratio: | 21.11 |
---|---|
Forward P/E Ratio: | 16.55 |
AVY Technical Analysis vs Fundamental Analysis
Buy
53
Avery Dennison (AVY)
is a Buy
Is Avery Dennison a Buy or a Sell?
-
Avery Dennison stock is rated a BuyThe current Avery Dennison [AVY] share price is $184.36. The Score for AVY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.